Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined t cell pathogenesis in HIV infection

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2099-2108

  Buggert, Marcus ^a   Frederiksen, Juliet ^b   Noyan, Kajsa ^a   Svard, Jenny ^c   Barqasho, Babilonia ^a   Sonnerborg, Anders ^a,c   Lund, Ole ^b   Nowak, Piotr ^a,c   Karlsson, Annika C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RO ANTIGEN;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CD4 CD8 RATIO; CD4 LYMPHOCYTE PERCENTAGE; CD8 LYMPHOCYTE PERCENTAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY T LYMPHOCYTE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTIGENS, CD; CD4-CD8 RATIO; COMPUTATIONAL BIOLOGY; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE;

EID: 84896519361     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302596     Document Type: Article

References (46)

1. Appay, V., and D. Sauce. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214: 231-241.
2. Benecke, A., M. Gale, Jr., and M. G. Katze. 2012. Dynamics of innate immunity are key to chronic immune activation in AIDS. Curr. Opin. HIV AIDS 7: 79-85.
3. Bosinger, S. E., D. L. Sodora, and G. Silvestri. 2011. Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr. Opin. HIV AIDS 6: 411-418.
4. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52: 10-18.
5. Hazenberg, M. D., J. W. Stuart, S. A. Otto, J. C. Borleffs, C. A. Boucher, R. J. De Boer, F. Miedema, and D. Hamann. 2000. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95: 249-255.
6. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169: 3400-3406.
7. Deeks, S. G., C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narváez, P. Hunt, J. N. Martin, J. O. Kahn, J. Levy, et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
8. Giorgi, J. V., R. H. Lyles, J. L. Matud, T. E. Yamashita, J. W. Mellors, L. E. Hultin, B. D. Jamieson, J. B. Margolick, C. R. Rinaldo, Jr., J. P. Phair, and R. Detels; Multicenter AIDS Cohort Study. 2002. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 29: 346-355.
9. Liu, Z., W. G. Cumberland, L. E. Hultin, A. H. Kaplan, R. Detels, and J. V. Giorgi. 1998. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18: 332-340.
10. Evans, T. G., W. Bonnez, H. R. Soucier, T. Fitzgerald, D. C. Gibbons, and R. C. Reichman. 1998. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells. Antiviral Res. 39: 163-173.
11. Tilling, R., S. Kinloch, L. E. Goh, D. Cooper, L. Perrin, F. Lampe, J. Zaunders, B. Hoen, C. Tsoukas, J. Andersson, and G. Janossy; Quest Study Group. 2002. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 16: 589-596.
12. Bisset, L. R., R. W. Cone, W. Huber, M. Battegay, P. L. Vernazza, R. Weber, P. J. Grob, and M. Opravil. 1998. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS 12: 2115-2123.
13. Sauce, D., J. R. Almeida, M. Larsen, L. Haro, B. Autran, G. J. Freeman, and V. Appay. 2007. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 21: 2005-2013.
14. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
15. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
16. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
17. Kaufmann, D. E., D. G. Kavanagh, F. Pereyra, J. J. Zaunders, E. W. Mackey, T. Miura, S. Palmer, M. Brockman, A. Rathod, A. Piechocka-Trocha, et al. 2007. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8: 1246-1254.
18. Yamamoto, T., D. A. Price, J. P. Casazza, G. Ferrari, M. Nason, P. K. Chattopadhyay, M. Roederer, E. Gostick, P. D. Katsikis, D. C. Douek, et al. 2011. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood 117: 4805-4815.
19. Deeks, S. G. 2011. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62: 141-155.
20. Brenchley, J. M., N. J. Karandikar, M. R. Betts, D. R. Ambrozak, B. J. Hill, L. E. Crotty, J. P. Casazza, J. Kuruppu, S. A. Migueles, M. Connors, et al. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720.
21. Desai, S., and A. Landay. 2010. Early immune senescence in HIV disease. Curr. HIV/AIDS Rep. 7: 4-10.
22. Kalayjian, R. C., A. Landay, R. B. Pollard, D. D. Taub, B. H. Gross, I. R. Francis, A. Sevin, M. Pu, J. Spritzler, M. Chernoff, et al; Adult AIDS Clinical Trial Group 5015 Protocol Team; Adult AIDS Clinical Trial Group 5113 Protocol Team. 2003. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J. Infect. Dis. 187: 1924-1933.
23. Sainz, T., S. Serrano-Villar, L. Diaz, M. I. Gonzalez-Tome, M. D. Gurbindo, M. I. Jose, M. J. Mellado, J. T. Ramos, J. Zamora, S. Moreno, and M. A. Munoz-Fernandez. 2013. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS. 27: 1513-1516.
24. Serrano-Villar, S., C. Gutiérrez, A. Vallejo, B. Hernández-Novoa, L. Díaz, M. Abad Fernández, N. Madrid, F. Dronda, J. Zamora, M. A. Munoz-Fernández, and S. Moreno. 2013. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J. Infect. 66: 57-66.
25. Buggert, M., M. M. Norström, C. Czarnecki, E. Tupin, M. Luo, K. Gyllensten, A. Sönnerborg, C. Lundegaard, O. Lund, M. Nielsen, and A. C. Karlsson. 2012. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. PLoS ONE 7: e39874.
26. Norström, M. M., M. Buggert, J. Tauriainen, W. Hartogensis, M. C. Prosperi, M. A. Wallet, F. M. Hecht, M. Salemi, and A. C. Karlsson. 2012. Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B5701 subjects. J. Virol. 86: 9802-9816.
27. R Core Team. 2012. R: A language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing. Available at: http:// www.R-project.org/.
28. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
29. Aghaeepour, N., P. K. Chattopadhyay, A. Ganesan, K. O'Neill, H. Zare, A. Jalali, H. H. Hoos, M. Roederer, and R. R. Brinkman. 2012. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays. Bioinformatics 28: 1009-1016.
30. Bendall, S. C., E. F. Simonds, P. Qiu, A. D. Amir, P. O. Krutzik, R. Finck, R. V. Bruggner, R. Melamed, A. Trejo, O. I. Ornatsky, et al. 2011. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332: 687-696.
31. Duraiswamy, J., C. C. Ibegbu, D. Masopust, J. D. Miller, K. Araki, G. H. Doho, P. Tata, S. Gupta, M. J. Zilliox, H. I. Nakaya, et al. 2011. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. J. Immunol. 186: 4200-4212.
32. Charlton, J. J., I. Chatzidakis, D. Tsoukatou, D. T. Boumpas, G. A. Garinis, and C. Mamalaki. 2013. Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner. J. Immunol. 190: 6104-6114.
33. Okoye, A. A., and L. J. Picker. 2013. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol. Rev. 254: 54-64.
34. Eller, M. A., K. G. Blom, V. D. Gonzalez, L. A. Eller, P. Naluyima, O. Laeyendecker, T. C. Quinn, N. Kiwanuka, D. Serwadda, N. K. Sewankambo, et al. 2011. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans. PLoS ONE 6: e18779.
35. Wikby, A., P. Maxson, J. Olsson, B. Johansson, and F. G. Ferguson. 1998. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 102: 187-198.
36. Wikby, A., B. Johansson, F. Ferguson, and J. Olsson. 1994. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp. Gerontol. 29: 531-541.
37. Huppert, F. A., E. M. Pinto, K. Morgan, and C. Brayne. 2003. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech. Ageing Dev. 124: 449-451.
38. Ferguson, F. G., A. Wikby, P. Maxson, J. Olsson, and B. Johansson. 1995. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J. Gerontol. A Biol. Sci. Med. Sci. 50: B378-B382.
39. Strindhall, J., B. O. Nilsson, S. Löfgren, J. Ernerudh, G. Pawelec, B. Johansson, and A. Wikby. 2007. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 42: 753-761.
40. Gratama, J. W., A. M. Naipal, M. A. Oosterveer, T. Stijnen, H. C. Kluin-Nelemans, L. A. Ginsel, G. J. den Ottolander, A. C. Hekker, J. D'Amaro, M. Van der Giessen, et al. 1987. Effects of herpes virus carrier status on peripheral T lymphocyte subsets. Blood 70: 516-523.
41. Khan, N., A. Hislop, N. Gudgeon, M. Cobbold, R. Khanna, L. Nayak, A. B. Rickinson, and P. A. Moss. 2004. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173: 7481-7489.
42. Solana, R., R. Tarazona, A. E. Aiello, A. N. Akbar, V. Appay, M. Beswick, J. A. Bosch, C. Campos, S. Cantisán, L. Cicin-Sain, et al. 2012. CMV and immunosenescence: from basics to clinics. Immun. Ageing 9: 23.
43. Taylor, J. M., J. L. Fahey, R. Detels, and J. V. Giorgi. 1989. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J. Acquir. Immune Defic. Syndr. 2: 114-124.
44. Lederman, M. M., L. Calabrese, N. T. Funderburg, B. Clagett, K. Medvik, H. Bonilla, B. Gripshover, R. A. Salata, A. Taege, M. Lisgaris, et al. 2011. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J. Infect. Dis. 204: 1217-1226.
45. Hunt, P. W., H. L. Cao, C. Muzoora, I. Ssewanyana, J. Bennett, N. Emenyonu, A. Kembabazi, T. B. Neilands, D. R. Bangsberg, S. G. Deeks, and J. N. Martin. 2011. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25: 2123-2131.
46. Kuller, L. H., R. Tracy, W. Belloso, S. De Wit, F. Drummond, H. C. Lane, B. Ledergerber, J. Lundgren, J. Neuhaus, D. Nixon, et al; INSIGHT SMART Study Group. 2008. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5: e203.